TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 0 | 4 | 16 | -9 | -3 | -11 | -0 | 
| P | %wins | 50 | 100 | 100 | 50 | 50 | 0 | 58 | 
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/17/21 16:48  | 9/17/21  | TYRA | Tyra Biosciences, Inc. | Health | Drug | Pharmaceutical Preparations | More Robert J | CA | D | P.d | 2,500 | 16.00 | 0 | 156 | 4 | 4,080 | I | ||||||||||||||||
6/30/15 18:11  | 6/24/15  | GKOS | Glaukos Corp | DE | Health | MdEq | Surgical & Medical Instrument | More Robert J | CA | D | P | 90 | 18.00 | 33 | 5 | New | 5 | D | -3 | 0 | 11 | -23 | -12 | -4 | |||||||||
5/1/07 17:24  | 5/1/07  | OREX | Orexigen Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | More Robert J | NJ | T | P.d | 6,300 | 12.00 | 0 | 525 | 13 | 4,549 | I | 3 | 8 | 21 | 6 | 7 | -18 | |||||||||
5/16/06 12:06  | 5/15/06  | NOVC | Novacea Inc | DE | Health | Drug | Pharmaceutical Preparations | More Robert J | NJ | T | P.d | 3,000 | 6.50 | 0 | 462 | 12 | 4,250 | B | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |